Research has focused on a drug called GS-441524, which inhibits the replication of the virus responsible for FIP. Studies have reported remarkable success rates, with many cats experiencing complete remission.
The new treatment is set to become legally available in the US on June 1, 2024 which could change the landscape of FIP treatment and bring hope to countless cat owners.